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ABSTRACT
The emergence of antibiotic-resistant Pseudomonas aeruginosa is one of main 
health issues in global communities. To overcome such threat, the discovery of 
novel antibacterial agents is indispensable. This study aimed to evaluate the in 
vivo antipseudomonal activity of Ulva reticulata extract in Drosophila model of 
infection. Ethanolic extract of Ulva reticulata was prepared using maceration 
method and the extract was subsequently assessed for its in vivo antibacterial 
effect against P. aeruginosa using survival assay, bacterial load enumeration, and 
gene expression analysis in the wildtype Drosophila. Survival and bacterial load 
analysis were further performed in a similar fashion on the mutant flies devoid of 
component responsible in the activation of immune responses against P. aeruginosa. 
Decline in the survival of infected host accompanied by augmentation of bacterial 
proliferation was documented in the wildtype Drosophila upon infection with P. 
aeruginosa. These phenotypic events were further amplified in immune-deficient 
mutant Drosophila. Nevertheless, improvement of host survivorship and reduction 
of bacterial burden were demonstrated in both wildtype or immune-deficient 
mutant flies upon treatment with Ulva reticulata extract after bacterial challenge. 
Our data demonstrated in vivo antipseudomonal activity of Ulva reticulata extract 
and thus provide a valuable information about its future potential for health 
promotion.
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1. Introduction
The emergence of pathogenic bacteria that are 
resistant to antibiotics presents a serious problem to 
the stability of public health (Levy and Marshall 2004; 
Gelband et al. 2015). One of such bacteria is Pseudomonas 
aeruginosa. Although P. aeruginosa lives commensally in 
the skin and mucous membranes, this pathogen most 
often causes primary infection through air contact in 
open wounds and/or nosocomial infections through the 
installation of medical devices (Mesaros et al. 2007). 
Currently, the use of appropriate antibiotics is the main 
choice to overcome cases of infection due to antibiotic-
resistant P. aeruginosa. However, with the limited 
selection of functional antibiotics (Luepke et al. 2017; 
WHO 2017), the discovery of novel antibacterial agents 
that are meticulously effective against P. aeruginosa is 
urgently required. 
To date, antibacterial drug discovery was achieved 
through the exploration of numerous potential sources 
(Lewis 2013; Wright 2014). One of promising sources for 
such efforts is green algae Ulva reticulata. This marine 
green alga belongs to the cosmopolitan genus Ulva and 
it is widely distributed in the tropical parts of Indo-
west-Pacific region, including Indonesia (Tilmann et al. 
2004; Tsai et al. 2004; Takeshi et al. 2005; Yabe et al. 
2009). Whilst the unsolicited presence of Ulva spp. in the 
coastal regions has been reported to have a detrimental 
effect on the social and tourism activities (Leliaert et al. 
2009; Yabe et al. 2009), different preparations of Ulva 
reticulata has been traditionally used as nutritional 
sources (Ratana-arporn and Chirapart 2006; Kim et 
al. 2011) and nowadays has been suggested to have 
numerous health benefits (Balaji et al. 2004; Hong et 
al. 2007; Hong et al. 2011). In addition, recent reports 
described that ethanolic extract of Ulva reticulata 
demonstrated excellent in vitro activities against several 
human pathogenic bacteria, including P. aeruginosa (Al-
Saif et al. 2014; Ravikumar et al. 2016). Unfortunately, 
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despite such potential, little information is available 
regarding the in vivo antibacterial activity of this 
particular marine species against P. aeruginosa.
We recently reported the use of a rapid and low-
cost in vivo fruit fly (Drosophila melanogaster) infection 
platform to examine the antibacterial potential of 
green algae Ulva reticulata (Nainu et al. 2018) and 
roselle (Hibiscus sabdariffa L.) calyx (Ahsan et al. 2019) 
extracts against Staphylococcus aureus. With the use 
of two straightforward assays: determination of fly 
survivorship and enumeration of bacterial colonies 
recovered from fly samples, we compared the 
susceptibility of the wild type and immune-deficient 
fruit flies to S. aureus infection in the presence or 
absence of treatment. Indeed, D. melanogaster has been 
acclaimed as one of appropriate model organisms in the 
discovery of evolutionally conserved immune-related 
effectors and signaling pathways in the infection caused 
by bacteria (Hoffman and Reichhart 2002; Buchon et al. 
2014; Panayidou et al. 2014) and viruses (Mussabekova 
et al. 2017; Nainu et al. 2017; Swevers et al. 2018).
To date, fruit fly has been used at the forefront of 
modern medical sciences to study biological events 
that are critically important in the human diseases 
(Pandey and Nichols 2011; Ugur et al. 2016). With 
a relatively high degree of genetic similarity with 
human (Pandey and Nichols 2011) and the fact that 
D. melanogaster was shown as an appropriate host for 
P. aeruginosa (D'Argenio et al. 2001; Apidianakis and 
Rahme 2009; Mulcahy et al. 2011; Haller et al. 2014), 
this particular insect offers huge and relevant benefits as 
an in vivo model organism in the field of antimicrobial 
drug discovery (Chamilos et al. 2011; Tzelepis et al. 
2013; Nainu 2018). What is more, the application of 
D. melanogaster as a model organism in the in vivo 
experiments offers a great deal of simplicity to work 
with large number of animals at the same time, requires 
small attention in the stock keeping, and raises little 
or even no issues in the ethical point of view (Pandey 
and Nichols 2011; Ugur et al. 2016). With all of these 
advantages, we carried out an experimental research 
to investigate the in vivo antipseudomonal activity of 
green algae Ulva reticulata.
2. Materials and Methods
2.1. Bacterial Strains and Fly Stocks
Culture of P. aeruginosa ATCC 27853 strain was used 
as infectious agent in all bacterial infection experiments 
performed in this study. Appropriate inoculum of 
bacteria was prepared by culturing the bacteria in 
Nutrient Broth (NB) medium at 37°C for 1 × 24 hours 
and processed thoroughly by a series of washing with 
PBS prior to quantification using spectrophotometry 
method. Bacterial inoculum was freshly prepared in PBS 
for each experiment. The following fly lines were used in 
this study: w1118 as genetic background (control) line and 
imd1 as immune-deficient fly line with undetected level 
of Imd (both Drosophila lines were generously provided 
by Prof. Yoshinobu Nakanishi, Kanazawa University). 
Male flies were used in the entire experiments and 
they were anesthetized with CO2 prior to carrying out 
bacterial infection experiments. Flies were maintained 
in standard conditions (25°C, 12:12 h light:dark cycle, 
standard cornmeal-agar food). 
2.2. Plant Extract Preparation
Fresh samples of the green algae Ulva reticulata 
were obtained from Puntondo, Takalar, South 
Sulawesi, Indonesia and processed immediately as 
previously described by Al-Saif et al. (2014), with 
slight modifications. Green algae samples were sorted 
and subjected to maceration procedures using 96% 
ethanol for 3 x 24 hours and re-macerated for 1 x 24 
hours. The resulting filtrates were collected and further 
processed using rotavapor to reduce the water content. 
The process was carried out thoroughly until extract 
with appropriate thickness were successfully obtained. 
The resulting extract was subsequently kept in a brown 
silica container prior to use.
 
2.3. Fly Infection and Assays for Survival and 
Bacterial Growth
All bacterial infection experiments were carried out 
using pricking method, as described previously (Nainu 
et al. 2018; Ahsan et al. 2019). In this method, adult 
male flies at age of 4–7 days after eclosion (15 flies 
per vial, 3 vials per group in each experiment) were 
subjected to infection procedure in which bacteria were 
introduced into the thorax of adult flies (0.9 × 105 cfu/ml 
per fly) and flies were further maintained in incubator 
with steady temperature at 29°C. A group of mock-
infected flies were prepared as a control group in each 
infection experiment. These flies were similarly treated 
but pricked with PBS instead of bacterial inoculum. 
Mock-infected and bacterial-infected flies were then 
subsequently subjected to either survival assay or 
colony forming assay as described previously (Nainu 
et al. 2018; Ahsan et al. 2019). In the survival assay, 
groups of flies were pricked with either P. aeruginosa 
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or PBS and maintained in the presence or absence of 
treatments. Daily observation was carried out to record 
the number of live flies at each group as designated. In 
the colony forming assay, groups of flies were subjected 
to similar procedures as in the survival assay but at a 
given time, live flies were taken from each group and 
mechanically processed using a micropestle in PBS 
solution. Homogenates obtained from all groups were 
independently prepared at serial dilutions, plated on 
Cetrimide agar (CETA) medium, and incubated at 37°C 
for 1 x 24 hours. Number of colonies appeared after 
incubation was expressed as cfu per ml.
2.4. Gene Expression Analysis
Isolation of total RNA was carried out on designated 
groups of treatments. In this assay, five live Drosophila 
were collected from each group at 50 hours post 
infection and transferred into Treff tubes. Flies were then 
homogenized in the Treff tube using a micropestle prior 
to further processing using SV Total RNA Isolation System 
(Promega) according to the manufacturer’s protocol. 
Level of diptericin (Dpt) was quantitatively determined 
in the RNA preparations using reverse transcriptase 
quantitative PCR (RT-qPCR) method based on the use of 
one set of Dpt primer (sequence of Dpt forward primer: 
5’–GCTGCGCAATCGCTTCTACT-3’ and sequence of Dpt 
reverse primer: 5’–TGGTGGAGTGGGCTTCATG-3’) in a 
20 µl reaction volume using GoTaq® 1-Step RT-qPCR 
System (Promega), as per manufacturer’s instruction. 
Rotor-Gene Q thermal cycler (Qiagen, Germany) was 
used with the following profile: 37°C for 15 mins, 95°C 
for 10 mins, and 40 cycles of 95°C for 10 s and 60°C for 
30 s, and 72°C for 30 s. To confirm that only the expected 
product had been amplified, a standard melt curve 
analysis was carried out in every run. Using a similar RT-
qPCR protocol, RNA level of host ribosomal protein rp49 
(used as an internal control) was examined by using one 
set of rp49 primer (sequence of rp49 forward primer: 
5’-GACGCTTCAAGGGACAGTATCTG-3’ and sequence of 
rp49 reverse primer: 5’-AAACGCGGTTCTGCATGA G-3’). 
The relative abundance of Dpt to the host reference 
gene rp49 was analyzed using qGENE software.
2.5. Data Processing and Statistical Analysis
In this study, results obtained from at least three 
independent biological replicates were statistically 
analyzed using GraphPad Prism® 7. Survival of flies 
during infection was displayed as a Kaplan-Meier 
curve and analysed using log-rank analysis. For 
results obtained in the CFU and gene expression 
experiments, data were prepared as bar graphs and 
analyzed statistically using one-way ANOVA. Data from 
all experiments are presented as mean ± S.D and p 
values of less than 0.05 were considered significant.
3. Results
3.1. Reproduction of Drosophila Model of P. 
aeruginosa Infection 
Apidianakis and Rahme previously published a 
procedure for the infection of D. melanogaster with P. 
aeruginosa. They suggested that flies can be inoculated 
with P. aeruginosa either by feeding, needle pricking, or 
injection. Based on the ease of technique and availability 
of equipment, we decided to use the needle pricking 
technique. In this study, we infected 4-7 days of male 
D. melanogaster with P. aeruginosa, a Gram-negative 
bacterium that have been reported to cause multitude 
of clinically relevant diseases on humans and other 
species such as nematodes and insects, including D. 
melanogaster. We selected one characteristic, alterations 
in the flies’ survival rate, as an indication of the 
infection success. As shown in Figure 1, infection of 
D. melanogaster w1118 with different concentration of 
P. aeruginosa stocks resulted in the dose-dependent 
reduction of flies’ survival rate, suggesting that the 
infection condition was successfully established in all 
three independent experiments and the needle pricking 
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Figure 1. Dose-response of P. aeruginosa in the infection 
experiment. (a) Adult w1118 flies at 4-7 days after 
eclosion were infected with a range of doses 
of P. aeruginosa by pricking and subjected to 
fly survival analysis. (b) Adult w1118 flies at 4-7 
days after eclosion were infected with 0.9 x 
105 cfu/ml of P. aeruginosa (PA) by pricking and 
subjected to fly survival analysis in the presence 
of tetracycline (TET) at different concentrations
technique was sufficient to yield reproducible results, 
at least in our hands.
In this experiment, we intended to use D. melanogaster 
as an in vivo platform to assess the antibacterial effect 
of green algae Ulva reticulata on P. aeruginosa. However, 
we have not established a proper antibiotic to be used 
as a positive control for our infection experiments. 
We previously confirmed that treatment of S. aureus-
infected Drosophila w1118 with tetracycline, a potent 
bacteria protein synthesis inhibitor, was sufficient to 
prevent host early death phenotype. Since tetracycline 
is a broad-acting antibiotic, we believed that this drug 
would also provide antibacterial protection against 
P. aeruginosa in D. melanogaster. To assess the effect 
of tetracycline on the survival of infected flies, we 
incubated P. aeruginosa-infected D. melanogaster in a vial 
with food containing tetracycline. Indeed, tetracycline 
treatment prevented early death phenotype on the 
infected flies (data not shown), thus confirmed its 
suitability to be used as the positive control in our 
further infection experiments.
3.2. Dose-dependent Effect of Ulva reticulata 
Extract in The Survival of Adult Drosophila 
melanogaster
Next, we carried out a survival assay to examine the 
possible antibacterial effect of green algae Ulva reticulata 
extract against P. aeruginosa. In this experiment, we 
infected adult males of w1118 flies with 0.9 x 105 cfu/
ml of P. aeruginosa and incubated them at 29°C in 
the presence or absence of Ulva reticulata extract at 
different concentrations. As shown in Figure 2a, flies 
were succumbed to immediate death upon P. aeruginosa 
infection and apparently, the survival of infected flies 
was not improved if maintained in foods containing 
Ulva reticulata extract at lower concentrations (0.1 and 
0.5% w/w). Nevertheless, the survivorship of infected 
flies became greatly enhanced once maintained in the 
presence of Ulva reticulata extract at a concentration 
as much as 2.5% w/w or tetracycline. From this 
experiment we demonstrated that the presence of 
certain concentration of Ulva reticulata extract in the 
food was sufficient to rescue P. aeruginosa-infected D. 
melanogaster from early death phenotype, indicating 
the in vivo antibacterial effect of Ulva reticulata extract 
against P. aeruginosa was achieved in a dose-dependent 
manner. 
3.3. Inhibition of Pseudomonas aeruginosa 
Growth by Green Algae Ulva reticulata
Increased mortality of D. melanogaster upon bacterial 
infection has been shown to be linearly correlated with 
increased bacterial load thus inhibition of bacterial 
growth by antibacterial agent was one of the ways to 
improve the survival of infected host. In support to 
this notion, we expected the reduction of pathogenic 
burden (P. aeruginosa load) will be demonstrated by 
the infected flies treated with either tetracycline (as 
a positive control) or 2.5% Ulva reticulata extract. To 
assess this, we carried out a simple colony forming 
assay using Cetrimide agar (CETA) as the specific growth 
medium for P. aeruginosa. As a result of this assay, we 
found that treatment of P. aeruginosa-infected flies 
with either tetracycline or Ulva reticulata extract was 
greatly useful to reduce the bacterial load (Figure 
2b), suggesting that bacterial growth inhibition by 
tetracycline or Ulva reticulata extract could lead to 
the increased survivorship of infected flies.
3.4. Ulva reticulata-mediated Antibacterial 
Protection is Independent of Diptericin 
Overstimulation
In response to infection by Gram-negative 
bacteria, Drosophila expressed a number of 
genetically-encoded antimicrobial peptides (AMP) 
that functionally work as a part of its innate immune 
responses. Taken this into account, we speculated 
that protection of infected flies observed in the 
group treated with Ulva reticulata extract might be 
achieved either by direct antibacterial effect against 
P. aeruginosa or by overstimulation of specific 
host immune responses. Of the known AMPs in 
Drosophila, a particular AMP named as Diptericin, 
which is encoded by the diptericin (dpt) gene, has 
been suggested to play a significant role against 
Gram-negative bacteria such as P. aeruginosa. To 
confirm whether overexpression of Diptericin plays a 
part in the host protection against P. aeruginosa upon 
treatment with Ulva reticulata extract, we assessed 
the expression level of diptericin in all designated 
groups. As shown in Figure 3, we detected an increased 
expression of diptericin in samples prepared from 
flies infected with P. aeruginosa, clearly indicating 
that Diptericin is expressed in a manner dependent 
on infection. Moreover, treatment of P. aeruginosa-
infected flies with either tetracycline or Ulva 
reticulata extract resulted in the reduced expression 
of diptericin, further clarifying the insignificant role 
of Diptericin in Ulva reticulata-mediated protection 
of Drosophila against P. aeruginosa.
3.5. Protection of Immune-deficient Drosophila 
Against P. aeruginosa by Ulva reticulata Extract
We observed that green algae Ulva reticulata 
extract exerts its antibacterial effect in the wildtype 
host upon infection with P. aeruginosa and such 
protection was not due to the overstimulation of 
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Diptericin, a specialized AMP commonly expressed 
in D. melanogaster to fight against Gram-negative 
bacteria, including P. aeruginosa. Based on these 
results, we believed that Ulva-reticulata-mediated 
antibacterial protection was achieved from direct 
interaction between antibacterial compounds 
contained in the extract and P. aeruginosa 
components in infected flies. To further support this 
view with data, we carried out infection experiments 
on immune-deficient flies lacking for Imd pathway 
that has been previously shown to have impaired 
production of Diptericin. As shown in Figure 4, 
we observed that the survival rate of imd1 mutant 
flies was dramatically declined upon P. aeruginosa 
infection (Figure 4a) and these immunodeficient flies 
tend to contain high bacterial load, around 100-folds 
higher than their mock-infected counterparts (Figure 
4b). Nonetheless, treatment of P. aeruginosa-infected 
immune-deficient fly line lacking for Imd pathway 
with either tetracycline or Ulva reticulata extract 
at concentration of 2.5 % (w/w) was deliberately 
adequate to improve flies’ survivorship (Figure 4a) 
and significantly helpful to reduce bacterial growth 
(Figure 4b) during the time of infection. These results 
further clarified that antipseudomonal activity of 
Ulva reticulata extract in adult Drosophila was not due 
to the involvement of Imd-mediated production of 
Diptericin.
4. Discussion
Pseudomonas aeruginosa has been famously known 
as one of pathogenic bacteria with considerable 
medical importance (Mesaros et al. 2007). In fact, 
accumulating evidence has suggested that some of 
the P. aeruginosa isolates develop the ability to resist 
the effect of a broad range of antibiotics, termed as 
antibiotic-resistant P. aeruginosa (Mesaros et al. 2007; 
Jorgensen et al. 2015), thus jeopardizing our efforts to 
maintain the public health stability in the world. With 
such threat, P. aeruginosa would be an appropriate 
target for antibacterial drug discovery
Pseudomonas aeruginosa is a bacilliform, 
facultative anaerobe, Gram-negative bacterium that 
is easily characterized by the presence of two specific 
metabolites–pyocyanin and pyoverdine–that gives 
the detectable blue-green color characteristics on the 
Cetrimide agar culture plate (Jorgensen et al. 2015). The 
production of bright green color due to combinatory 
reaction between fluorescent pigment pyoverdin and 
blue hydrophilic pigment pyocyanin has been used as a 
positive indication of the P. aeruginosa presence in the 
tested samples (Jorgensen et al. 2015).
 Recently, we demonstrated the use of adult D. 
melanogaster as a novel, straightforward and low-cost 
in vivo platform to examine the antibacterial activity 
of Ulva reticulata extract (Nainu et al. 2018) and roselle 
Figure 2. Improvement of host survival and reduced bacterial load in infected flies in the presence Ulva reticulata extract. 
Adult w1118 flies at 4-7 days after eclosion were infected with 0.9 x 105 cfu/ml of P. aeruginosa (PA) by pricking, 
incubated at 29°C in the presence of 2.5% Ulva reticulata extract, and subjected to fly survival (a) and bacterial 
load (b) analysis. Flies treated with tetracycline (TET) at 200 µg/ml were used as a positive control group
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(Hibiscus sabdariffa L.) calyx extract (Ahsan et al. 2019) 
against S. aureus infection. Here, we employed such in 
vivo platform to assess the antipseudomonal activity 
of Ulva reticulata extract. We used similar approaches: 
assessment of fly survival assays and numerical 
determination of colony forming bacteria, to investigate 
the antibacterial effect of Ulva reticulata extract against 
P. aeruginosa infection. In conjunction with molecular 
analysis to examine the expression of Diptericin, a 
well-known Drosophila immune response against 
Gram-negative bacteria, data obtained in this study 
clearly indicated the antipseudomonal activity of Ulva 
reticulata extract and such antibacterial protection was 
achieved independent of Diptericin-mediated immune 
responses in the affected host. In addition to that, 
direct comparison of survival rate and bacterial load 
analysis between w1118 and imd1 flies further validates 
the important role of Imd-mediated protection against 
P. aeruginosa infection, as reported by others (D’Argenio 
et al. 2001; Limmer et al. 2011). It would be interesting 
to see in the future research whether different 
components of the Imd signaling pathway and/or other 
antibacterial-related pathways such as Toll and JAK-
STAT pathways are overstimulated by the infected host 
in response to the ingestion of Ulva reticulata extract. 
Furthermore, while our data suggested the protective 
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Figure 3. Anti-pseudomonal protection of Ulva reticulata extract was achieved independent of Diptericin stimulation. (a) 
upon infection with Gram-negative bacteria, Diptericin is expressed in response to activation of Imd pathways 
in Drosophila. (b) adult w1118 flies at 4-7 days after eclosion were infected with 0.9 x 105 cfu/ml of P. aeruginosa 
(PA) by pricking, incubated at 29°C in the presence of 2.5% Ulva reticulata extract, and subjected to RNA isolation 
followed by Diptericin mRNA level quantification by RT-qPCR. Expression of reference gene rp49 was used as the 
internal control. Flies treated with tetracycline (TET) at 200 µg/ml were used as a positive control group
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effect of Ulva reticulata extract against P. aeruginosa 
in D. melanogaster, compound(s) responsible for 
such antibacterial effect are unknown. Certainly, the 
elucidation of compounds with antibacterial properties 
in Ulva reticulata extract is one of important directions 
to pursue in the future studies.  
The combination of two phenotypic analysis used in 
this study, survivorship of infected flies and enumeration 
of bacteria recovered from infected flies, has been 
recognized as a simple yet efficient way to investigate 
the antimicrobial properties of potential samples 
(Apidianakis and Rahme 2009; Nainu et al. 2018; Ahsan 
et al. 2019). By using this approach, researchers will 
be able to obtain appropriate compounds with in vivo 
activities at the initial screening and at the same time 
will be able to exclude compounds that are highly toxic 
to the eukaryotic host cells. In addition to that, a high 
degree of genetic similarity between D. melanogaster and 
human (around 75%) suggests a reasonable likelihood 
of getting similar results in the clinical trials of the 
respective drug candidates. Certainly, all advantages 
offered by Drosophila in vivo infection platform used 
in this study shall be a great rationale for researchers 
before moving to the next stage using mammalian 
animal models. Such approach will eventually support 
the rapid advancement of antimicrobial drug discovery 
in an inexpensive and logical manner.
5. Conclusion
In this study, for the first time, we confirmed the 
in vivo antipseudomonal activity of green algae Ulva 
reticulata extract using a novel, straight-forward and 
low-cost Drosophila platform system. This model 
is based on two phenotypic results: survival rate 
improvement and reduction of bacterial load, followed 
by the use of molecular analysis to rule out the potential 
immunostimulation activity of the assessed sample. 
With this data in hand, we further demonstrated the 
relevance of D. melanogaster as an in vivo platform 
to investigate the potential antibacterial activity of 
a particular sample of interest. With the abundance 
resources in Indonesia and other countries, such 
platform would serve as a great inexpensive in vivo 
approach to rapidly discover important antibacterial 
compounds from multiple sources of interests in no 
time.
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